307 related articles for article (PubMed ID: 27683187)
1. Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects.
Ratnatilaka Na Bhuket P; El-Magboub A; Haworth IS; Rojsitthisak P
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):341-353. PubMed ID: 27683187
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats.
Bangphumi K; Kittiviriyakul C; Towiwat P; Rojsitthisak P; Khemawoot P
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):777-785. PubMed ID: 26563392
[TBL] [Abstract][Full Text] [Related]
3. Curcumin - Bioavailability Enhancement by Prodrug Approach and Novel Formulations.
Chelimela N; Alavala RR; Satla SR
Chem Biodivers; 2024 May; 21(5):e202302030. PubMed ID: 38401117
[TBL] [Abstract][Full Text] [Related]
4. A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin.
Muangnoi C; Jithavech P; Ratnatilaka Na Bhuket P; Supasena W; Wichitnithad W; Towiwat P; Niwattisaiwong N; Haworth IS; Rojsitthisak P
Biosci Biotechnol Biochem; 2018 Aug; 82(8):1301-1308. PubMed ID: 29678124
[TBL] [Abstract][Full Text] [Related]
5. Cationic Ester Prodrugs of Curcumin with N,N-dimethyl Amino Acid Promoieties Improved Poor Water Solubility and Intestinal Absorption.
Hirano-Kusuda M; Setoguchi S; Koga M; Goto S; Yamada A; Watase D; Nagata-Akaho N; Karube Y; Matsunaga K; Takata J
Pharm Res; 2023 May; 40(5):1299-1310. PubMed ID: 37081301
[TBL] [Abstract][Full Text] [Related]
6. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
7. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
8. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
9. Current prodrug design for drug discovery.
Hsieh PW; Hung CF; Fang JY
Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
[TBL] [Abstract][Full Text] [Related]
10. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
Jana S; Mandlekar S; Marathe P
Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
[TBL] [Abstract][Full Text] [Related]
11. Evaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administration.
Duan Y; Zhang B; Chu L; Tong HH; Liu W; Zhai G
Colloids Surf B Biointerfaces; 2016 May; 141():345-354. PubMed ID: 26874910
[TBL] [Abstract][Full Text] [Related]
12. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
Müller CE
Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
[TBL] [Abstract][Full Text] [Related]
13. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
14. Acetal-linked polymeric prodrug micelles for enhanced curcumin delivery.
Li M; Gao M; Fu Y; Chen C; Meng X; Fan A; Kong D; Wang Z; Zhao Y
Colloids Surf B Biointerfaces; 2016 Apr; 140():11-18. PubMed ID: 26731193
[TBL] [Abstract][Full Text] [Related]
15. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions.
Yu H; Huang Q
J Agric Food Chem; 2012 May; 60(21):5373-9. PubMed ID: 22506728
[TBL] [Abstract][Full Text] [Related]
16. Development and pharmacokinetic evaluation of a curcumin co-solvent formulation.
John MK; Xie H; Bell EC; Liang D
Anticancer Res; 2013 Oct; 33(10):4285-91. PubMed ID: 24122994
[TBL] [Abstract][Full Text] [Related]
17. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
Nguyen MH; Yu H; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
[TBL] [Abstract][Full Text] [Related]
18. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.
Kanai M; Imaizumi A; Otsuka Y; Sasaki H; Hashiguchi M; Tsujiko K; Matsumoto S; Ishiguro H; Chiba T
Cancer Chemother Pharmacol; 2012 Jan; 69(1):65-70. PubMed ID: 21603867
[TBL] [Abstract][Full Text] [Related]
19. The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats.
Zheng Z; Sun Y; Liu Z; Zhang M; Li C; Cai H
Drug Des Devel Ther; 2015; 9():4931-42. PubMed ID: 26345159
[TBL] [Abstract][Full Text] [Related]
20. The use of esters as prodrugs for oral delivery of beta-lactam antibiotics.
Mizen L; Burton G
Pharm Biotechnol; 1998; 11():345-65. PubMed ID: 9760687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
